Ads
related to: Renal Cell Carcinoma- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- Clinical Trial Info
Review Clinical Trial Results For
This FDA-Approved Treatment Option.
- How This Treatment Works
Search results
David Braun, MD, PhD, on Biomarkers in Renal Cell Carcinoma
MedPage Today· 1 day agoFor patients with metastatic renal cell carcinoma (RCC), there are as yet no reliable biomarkers to...
The Key to Finding Predictive Biomarkers in Metastatic Renal Cell Carcinoma?
MedPage Today· 1 day agoIdentification of clinically meaningful, reproducible, and widely available prognostic and, more...
New PET agent provides same-day imaging for clear cell renal cell carcinoma patients
Medical Xpress· 7 days agoA novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published in the May issue of ...
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 1 day agoOpdivo is a programmed death-1 (PD-1) immune checkpoint inhibitor. It has been approved to treat a...
HUTCHMED begins trial for pancreatic ductal adenocarcinoma therapy
Clinical Trials Arena via Yahoo Finance· 5 hours agoIn December 2023, Hutchmed finished enrolling subjects in a Phase II/III clinical trial of...
Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 9 hours agoInc (NASDAQ:ALLO) received a $15 million grant from the California Institute for Regenerative Medicine, validating the therapeutic potential of its OUTLOOK 316 program for advanced ...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 4 days agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
Leads Biolabs is Proud to Announce its Participation in the 2024 ASCO Annual Meeting with One Oral...
WKRN Nashville· 2 days agoThe 2024 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago from May 31 to June 4, 2024. Leads Biolabs will present the exciting clinical data on its four innovative clinical programs at the ASCO meeting.
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Motley Fool via Yahoo Finance· 2 days agoExelixis Exelixis specializes in cancer medicines. It earned quite a reputation thanks to its most...
Wedbush Boosts Janux Therapeutics (NASDAQ:JANX) Price Target to $74.00
ETF DAILY NEWS· 3 days agoJanux Therapeutics (NASDAQ:JANX – Free Report) had its target price increased by Wedbush from $53.00 to $74.00 in a research note published on Wednesday morning, Marketbeat reports. The brokerage ...
Ads
related to: Renal Cell Carcinoma